Initiated by the ICMR in 2013, AMRSN delivers the accurate estimation of drug resistant infections and patterns of AMR among pathogens of human importance across Indian hospitals.

The promising leads and evidence of AMR brought forth by AMRSN is being used to devise and update the treatment guidelines with the help of collected data.

To strengthen the understanding of AMR at multiple levels, ICMR through its AMR surveillance network and various other collaborative research programs is helping to decode the ever-evolving mechanisms of resistance and other targets which could guide the development of new diagnostics, potential drug candidate and drug molecules.